Qube Research & Technologies (QRT)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,000
Closed -$55.2K 3716
2026
Q1
$55.2K Buy
+1,000
New +$54.2K ﹤0.01% 3156
2025
Q2
Sell
-150,400
Closed -$5.83M 3704
2025
Q1
$5.83M Hold
150,400
0.01% 1447
2024
Q4
$5.09M Buy
+150,400
New +$5.41M 0.01% 1490

Other funds holding GSK

Qube Research & Technologies (QRT)'s GSK Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its GSK (GSK) stake by 97% in Q2 2026, buying an estimated $28.1M and bringing the position to 1,078,767 shares worth $56.5M. The position accounts for 0.05% of the portfolio, ranked #457.

Qube Research & Technologies (QRT) first reported a position in GSK in Q1 2018 and has held it in 17 quarters since. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,078,767 shares of GSK worth $56.5M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 530,545 GSK shares in Q2 2026, an estimated $28.1M.
  • GSK made up 0.05% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #457 holding.
  • Qube Research & Technologies (QRT) first reported a position in GSK in Q1 2018 and has held it in 17 quarters since.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.